A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)
Trial details
- Registry ID
- NCT02942017
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)NCT02942017 | SUPN | Phase 3 | Completed | 2017-09-17Actual |
| A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)NCT02942004 | SUPN | Phase 3 | Completed | 2017-09-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |